Expertise in
19
conditions

Rachel Reynaud

CHU Angers
Angers, FR 
Expertise in
19
conditions
CHU Angers
Angers, FR 

Overview

Rachel Reynaud practices practicing medicine in Angers, France.

Ms. Reynaud is highly rated in 19 conditions, according to our data. Her clinical expertise encompasses Panhypopituitarism, Familial Hypopituitarism, Hypopituitarism, Sheehan Syndrome, and Hormone Replacement Therapy (HRT).

She is actively involved in clinical research, co-authoring 100 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

CHU Angers
Angers, 49000, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

The MiniMed™ 780G Glycemic Control and Quality of Life Study for the Treatment of Pediatric and Adult Subjects With Type 1 Diabetes in France (EQOL Study)
The MiniMed™ 780G Glycemic Control and Quality of Life Study for the Treatment of Pediatric and Adult Subjects With Type 1 Diabetes in France (EQOL Study)
Enrollment Status: Completed
Publish Date: July 08, 2024
Intervention Type: Device
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Humalog With an Open-Label Postprandial LY900014 Treatment Group in Children and Adolescents With Type 1 Diabetes
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Humalog With an Open-Label Postprandial LY900014 Treatment Group in Children and Adolescents With Type 1 Diabetes
Enrollment Status: Completed
Publish Date: January 24, 2022
Intervention Type: Drug
Study Drugs: LY900014, Insulin Lispro
Study Phase: Phase 3
View 1 Less Clinical Trial

100 Total Publications

Genotype-phenotype correlation and challenges in mutation detection in McCune-Albright syndrome: A retrospective study of a French cohort.
Genotype-phenotype correlation and challenges in mutation detection in McCune-Albright syndrome: A retrospective study of a French cohort.
Journal: Annales d'endocrinologie
Published: May 08, 2026

Frequently Asked Questions about Rachel Reynaud

Is Rachel Reynaud a top-rated expert for Panhypopituitarism?

MediFind is an objective health platform that identifies experts based on real-world data. Rachel Reynaud is classified as an Elite expert for Panhypopituitarism, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Rachel Reynaud participate in research or clinical trials?

Yes. Rachel Reynaud has published 100 articles and abstracts on conditions like Panhypopituitarism. You can view a list of Rachel Reynaud's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Reynaud's expertise for a condition
ConditionClose
View All 14 Advanced Conditions
View All 37 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile